Lingmei Li Selected Research

Neoplasms (Cancer)

1/2024	Eosinophilic Solid and Cystic Renal Cell Carcinoma: Morphologic and Immunohistochemical Study of 18 Cases and Review of the Literature.
1/2023	ISG15 targets glycosylated PD-L1 and promotes its degradation to enhance antitumor immune effects in lung adenocarcinoma.
1/2023	Cancer subtyping with heterogeneous multi-omics data via hierarchical multi-kernel learning.
3/2021	Characterization of a distinct low-grade oncocytic renal tumor (CD117-negative and cytokeratin 7-positive) based on a tertiary oncology center experience: the new evidence from China.
11/2018	Multidisciplinary team for the diagnosis and treatment of 2 cases of primary intestinal yolk sac tumor.
11/2016	FGF4 induces epithelial-mesenchymal transition by inducing store-operated calcium entry in lung adenocarcinoma.
7/2015	Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lingmei Li Research Topics

Disease

7	Neoplasms (Cancer) 01/2024 - 07/2015
3	Adenocarcinoma of Lung 01/2020 - 11/2016
2	Reperfusion Injury 11/2023 - 09/2023
2	Myocardial Ischemia (Ischemic Heart Diseases) 11/2023 - 09/2023
1	Disease Progression 01/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2022
1	Diabetes Mellitus 09/2022
1	Type 2 Diabetes Mellitus (MODY) 09/2022
1	Fatigue 01/2021
1	Ductal Carcinoma 02/2019
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Food Hypersensitivity (Food Allergy) 10/2016
1	Hypercholesterolemia 01/2016
1	Atherosclerosis 01/2016
1	Lung Neoplasms (Lung Cancer) 07/2015
1	Breast Neoplasms (Breast Cancer) 07/2015

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2015
3	Keratins (Keratin)IBA 01/2024 - 11/2018
2	shuangshen ningxinIBA 11/2023 - 09/2023
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2024
1	LipidsIBA 11/2023
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2023
1	Capsules (Microcapsules)IBA 09/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	omega-Chloroacetophenone (Mace)IBA 09/2022
1	Polytetrafluoroethylene (Teflon)FDA Link 03/2021
1	Keratin-7 (Cytokeratin 7)IBA 03/2021
1	tetrahydrofuranIBA 01/2021
1	SolutionsIBA 01/2021
1	Growth Factor ReceptorsIBA 02/2019
1	Estrogen ReceptorsIBA 02/2019
1	Progesterone Receptors (Progesterone Receptor)IBA 02/2019
1	VimentinIBA 11/2018
1	Coloring Agents (Dyes)IBA 11/2018
1	GlypicansIBA 11/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2018
1	CalciumIBA 11/2016
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 11/2016
1	Protein Isoforms (Isoforms)IBA 11/2016
1	Glycoproteins (Glycoprotein)IBA 10/2016
1	Mannose (D-Mannose)IBA 01/2016
1	Polysaccharides (Glycans)IBA 01/2016
1	CholesterolIBA 01/2016
1	Epidermal Growth Factor (EGF)IBA 07/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2015

Therapy/Procedure

1	Therapeutics 01/2023
1	Immunotherapy 01/2023
1	Percutaneous Coronary Intervention 09/2022